The TSX Venture Exchange has accepted for filing the amendment to the convertible loan and royalty agreement dated April 1, 2025, between the company and a non-arm's-length party. Pursuant to the terms of the amended agreement and for consideration thereto, the company has issued to the lender 22,263,733 common share purchase warrants, exercisable any time prior to Nov. 28, 2026, with an exercise price of 22.5 cents per underlying bonus warrant share.

For any further information, see the company's news releases dated March 6, 2025, April 1, 2025, and May 28, 2025.